TrialProceedings of the National Academy of Sciences of the United States of America2017

Class I-restricted T-cell responses to a polymorphic peptide in a gene therapy clinical trial for α-1-antitrypsin deficiency.

Roberto Calcedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.